Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection
Description
The severity of the SARS-CoV-2 pandemic and the recurring (re)emergence of viruses prompted the development of new therapeutic approaches that target viral and host factors crucial for viral infection. Among them, host peptidases cathepsins B and L
